The European Patent Office (EPO) has published patent application EP4255570A1, detailing "Anti-VEGF antibody constructs and related methods for treating vestibular schwannoma associated symptoms." The application lists Akouos, Inc. as the applicant and includes inventors Emmanuel John Simons, Robert Ng, and Michael McKenna. This publication represents a new patent filing in the field of therapeutic antibodies.

This publication is primarily informational for entities involved in pharmaceutical research and development, particularly those working on treatments for vestibular schwannoma or related conditions. It does not impose any new compliance obligations or deadlines on regulated entities. Compliance officers should note this publication as a development in the intellectual property landscape for relevant therapeutic areas.